登录

Well-healthcare Snares ¥10M in Series A Funding Round

作者: Mailman 2020-07-10 15:25
汇健科技
http://www.well-healthcare.com/
企业数据由 动脉橙 提供支持
肿瘤液体活检产品开发商 | 战略融资 | 运营中
中国-浙江
2022-04-07
悬壶汇智
查看

According to VCBeat, recently, Well-healthcare Technologies Co., Ltd. ("Well-healthcare") completed Series A financing worth tens of millions, led by Sinowisdom with participation from Thunderstorm VC and the existing shareholder SDIC Venture Capital.


Based on advanced nanometer semiconductor chips and artificial intelligence (AI) algorithms, Well-healthcare will accelerate the industrialization in the fields of high-throughput analysis in the clinical spectrum and AI-driven olfactory system after the completion of this round.


Well-healthcare is committed to develop diagnostic products in all kinds of clinical scenarios to meet the unmet clinical needs, provide precision medicine and health monitoring solutions. Its innovative products will play an important role in the diagnose of tumors, medication guidance, drug efficacy monitoring, and chronic disease management.


In 2019, Well-healthcare completed the Pre-A round of financing led by Miracle Light Venture, included SDIC Venture Capital and Yanmucao Investment, and carried out various R&D and industrialization work rapidly and orderly.


Well-healthcare has built a comprehensive testing platform with high-throughput spectrometry and sensing diagnosis system for multidimensional omics (peptide proteomics, metabolomics), multiple samples (blood, urine, saliva, breath gas, cells and tissues, etc.). The platform has significant advantages of high accuracy, strong stability and low cost.


Well-healthcare also made major progress in its pipelines. The company cooperated with leaders in the industry to develop the world's first sets of peptides identification in tumors, ClinMS-Plat®Ⅰ mass spectrometry diagnostics system, which is going to be launched. Besides, Well-healthcare built the first diagnostic reagent and AI-based liquid biopsy diagnosis model for colorectal cancers, which is called Bio-pSi®, with accuracy over 90%.


>>>>

About Sinowisdom


Sinowisdom, founded in 2002, is a Chinese domestic private investment venture capital management agency. The company has more than 60 funds under management, with AUM over 10 billion yuan. It has invested in more than 160 projects and 20% of its portfolios are listed now.


>>>>

About SDIC Venture Capital


Founded in 2016, SDIC Venture Capital is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market-driven governance structure. SDICVC currently manages four funds, with AUM at 14 billion yuan.

相关赛道 IVD
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

潜心深耕心脑计算医学领域,阅影科技完成数亿元A+轮融资

【首发】获万孚生物数千万元A轮独家投资,赛维森科技如何在AI辅助病理诊断赛道脱颖而出?

汇健科技完成数千万元A轮融资,加速布局创新诊断产品

圣澳云智:AI助力肿瘤诊断,提供从影像学到细胞学的肺癌联合早诊解决方案

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

New Horizon Health Snags $30M in Series E Funding Round

2020-07-10
下一篇

OBiO Technology Raises ¥200M in Pre-C Round

2020-07-10